Jeanmarie Guenot is the perfect example of a working woman conquering her chosen profession. She’s not solely focused on profits or moving up the company ladder. She has a passion for seeing medical advancements through to the end. Jeanmarie has worked in the advanced medicine and biotechnology industry for over 20 years. She has the same amount of experience as any man in her field. She has worked with both private and public companies. Her career has given her the opportunity to work in all stages of the pharmaceutical and biotechnology industry. She’s an expert at building and rebuilding several different kinds of businesses.
Most of her experience is working in research and development, but she has expertise in many other areas. She’s worked in corporate and commercial development, company development, project and alliance management, and even in venture capital departments. Currently, Jeanmarie is the President and Chief Executive Officer of Amphivena Therapeutics, Inc. Amphivena is a company that develops innovative bi-functional antibody therapies that help patients suffering from hematologic malignancies. Before Jeanmarie was President and CEO of Amphivena, she founded SKS Ocular. The start-up ophthalmic company focuses on developing ocular drug delivery therapeutic technology that combats glaucoma, macular degeneration, and ocular inflammation.
She also spent time as an advisor at Hoffmann-La Roche, a company with bases in Basel and Shanghai. That was the start of her business career. She went on to work as a Vice President at PDL BioPharma. While there, she was responsible for working with licensing, mergers and acquisitions, and alliance management for PDL’s research and development. She developed a knack for organizing and overseeing deals for businesses.
Jeanmarie Guenot’s website shows that she always had a passion was medicine. Even though she’s had an outstanding career in business, she feels most comfortable in the medical field. She trained in both physical and medicinal chemistry. She also studied X-ray and NMR refinement and modern drug design. She attended the University of California, San Francisco and the University of Pennsylvania. She earned her Ph.D. in California and her MBA in Pennsylvania.